EF
ADAP

Empirical Finance’s Adaptimmune Therapeutics ADAP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$192K Buy
+800,000
New +$192K 0.01% 504